Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
- 26 Juin 2024 - 1 mn de lecture
The purpose of this study is to evaluate the effect of an initial hormonal treatment gonadotrophin-releasing hormone (GnRH Agonist) on 2 biomarkers (PCA3 and TMPRSS2-ERG), in patients with histologically confirmed and advanced stages of prostate cancer. Their characteristics, according to risk factors such as PSA and Gleason score will be determined at baseline and 1, 3 and 6 month post-treatment.
26 Juin 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
26 Juin 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
26 Juin 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
26 Juin 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
26 Juin 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
26 Juin 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
26 Juin 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
26 Juin 2024
1 mn de lecture